Tamsulosin dissolution from pharmaceutical dosage forms using an automated HPLC system

被引:6
作者
Aboul-Enein, HY
Hussein, RF
Radwan, MA
Yusuf, A
Al-Ahmadi, W
Al-Rawithi, S
机构
[1] King Faisal Specialist Hosp & Res Ctr, Pharmaceut Anal Lab, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Pharmacokinet & Therapeut Drug Monitoring Lab, Riyadh 11211, Saudi Arabia
[3] King Saud Univ, Dept Women Students, Coll Pharm Sci & Med Studies, Dept Clin Pharm, Riyadh, Saudi Arabia
关键词
tamsulosin; photodiode array detector; dissolution; HPLC;
D O I
10.1081/JLC-120020097
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A novel, rapid, accurate, and sensitive high-performance liquid chromatographic assay was developed to determine tamsulosin (TAM) in pharmaceutical dosage forms and to follow its dissolution pattern. An efficient separation of TAM was performed using stainless steel Supelcosil LC-18 column (25 cm x 4.6 mm; 5 pm particle size) preceded by a Sentry guard column. The mobile phase consisted of an aqueous solution containing acetonitrile 70% (pH 3.4 adjusted with glacial acetic acid) and delivered at a flow rate of 0.75 mL/min. The compound of interest was detected using photodiode array detector at 225 nm. Under these conditions, the retention time for TAM was 6.1 +/- 0.2 min. The detector response was linear for TAM in alkaline solution (r > 0.9975) in the range of 0.025-1.00 mug/mL. The detection and the quantification limits for TAM were 0.015 and 0.025 mug/mL, respectively. No interferences were observed from the capsule's excipients. The drug content in each capsule ranged from 99 to 101%. The dissolution study of OMNIC(R) capsules revealed that TAM in USP media (pH 1.2) showed no dissolution up to 12 h. However, a first order release kinetic, with dissolution T-50% of about 2 h, was observed in USP media (pH 7.4).
引用
收藏
页码:1109 / 1116
页数:8
相关论文
共 7 条
[1]   Medical therapy for benign prostatic hyperplasia: A review of the literature [J].
Clifford, GM ;
Farmer, RDT .
EUROPEAN UROLOGY, 2000, 38 (01) :2-19
[2]   Quantitation of tamsulosin in human plasma by liquid chromatography-electrospray ionization mass spectrometry [J].
Ding, L ;
Li, LM ;
Tao, P ;
Yang, J ;
Zhang, ZX .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 767 (01) :75-81
[3]   Tamsulosin - A review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms [J].
Dunn, CJ ;
Matheson, A ;
Faulds, DM .
DRUGS & AGING, 2002, 19 (02) :135-161
[4]   USE OF AN ALPHA-1-BLOCKER, YM617, IN THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY [J].
KAWABE, K ;
UENO, A ;
TAKIMOTO, Y ;
ASO, Y ;
KATO, H .
JOURNAL OF UROLOGY, 1990, 144 (04) :908-912
[5]   Highly sensitive method for the determination of tamsulosin hydrochloride in human plasma dialysate, plasma and urine by high-performance liquid chromatography electrospray tandem mass spectrometry [J].
Matsushima, H ;
Takanuki, K ;
Kamimura, H ;
Watanabe, T ;
Higuchi, S .
JOURNAL OF CHROMATOGRAPHY B, 1997, 695 (02) :317-327
[6]   SENSITIVE METHOD FOR THE DETERMINATION OF AMSULOSIN IN HUMAN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
SOEISHI, Y ;
KOBORI, M ;
KOBAYASHI, SI ;
HIGUCHI, S .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 533 :291-296
[7]   Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics [J].
Taguchi, K ;
Schäfers, RF ;
Michel, MC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (01) :49-55